EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Loganin Modulates Inflammatory Signalling and Epidermal Alterations in an Imiquimod‐Induced Psoriasis Mouse Model

Eda Acikgoz iD, Cafer Tas iD, Mustafa Cakir iD, Seda Keskin iD

Journal of Biochemical and Molecular Toxicology · 2026-11 · 40 (11)

DOI: 10.1002/jbt.71178 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, online erschienen am 10.11.2026. Verfasst von Eda Acikgoz und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Histology and Embryology, Faculty of Medicine, Van Yuzuncu Yil University, Van, Turkey. Hauptthemen laut MEDLINE: Psoriasis, Imiquimod, Epidermis, Signal Transduction. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Van Yuzuncu Yil University Scientific Research Projects Coordination Unit, Scientific and Technological Research Council of Turkey, Türkiye Bilimsel ve Teknolojik Araştirma Kurumu.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Psoriasis is a chronic immune‐mediated inflammatory skin disease driven by abnormal interactions among keratinocytes, immune cells and cytokine networks. Dysregulated inflammatory signalling has been shown to exacerbate psoriatic inflammation. Loganin (LOG), a natural iridoid glycoside, exhibits anti‐inflammatory effects in experimental models, yet its relevance to psoriasis remains poorly characterised. This study investigated the effects of LOG during the development of IMQ‐induced psoriasis‐like inflammation, evaluating its influence on inflammatory signalling and associated tissue responses using PASI scoring, histopathology and stereology. Molecular and cellular alterations were assessed using qPCR, immunohistochemistry, immunofluorescence, and ELISA to determine changes in pro‐inflammatory cytokine profiles, NOD‐like receptor protein 3 (NLRP3) inflammasome components, markers of epidermal proliferation and keratinocyte remodelling, and vascular responses. Topical IMQ induced characteristic psoriatic alterations, including epidermal hyperplasia, immune cell infiltration, microvascular activation, and elevated pro‐inflammatory cytokines. LOG significantly attenuated IMQ‐associated body weight loss, reduced psoriatic clinical severity scores and epidermal thickening, and decreased proliferating cell nuclear antigen (PCNA) and cytokeratin‐17 (CK‐17) immunoreactivity. Furthermore, LOG attenuated vascular endothelial growth factor receptor‐2 (VEGFR2) immunoreactivity and decreased interleukin‐17A (IL‐17A) and interleukin‐1β (IL‐1β) levels, suggesting modulation of inflammatory and vascular responses. LOG also downregulated the expression of NLRP3, apoptosis‐associated speck‐like protein (ASC), and caspase‐1. Collectively, these findings indicate that LOG attenuates IMQ‐induced inflammatory responses and is associated with reduced expression of NLRP3 inflammasome‐related components. These findings support the anti‐inflammatory effects of LOG in the IMQ‐induced psoriasis model while indicating that further functional studies are required to determine whether LOG directly affects NLRP3 inflammasome activation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PsoriasisImiquimodEpidermisSignal TransductionAnimalsDisease Models, AnimalMiceInflammationNLR Family, Pyrin Domain-Containing 3 ProteinInflammasomesCytokinesMaleKeratinocytesIridoids

Stichwörter der Autor:innen

LoganinNLRP3 inflammasomeimiquimod‐induced psoriasis modelinflammatory signalling pathwaysskin inflammation

Substanzen

ImiquimodloganinNLR Family, Pyrin Domain-Containing 3 ProteinInflammasomesCytokinesNlrp3 protein, mouseIridoids

Autor:innen und Institutionen

  • Department of Histology and Embryology, Faculty of Medicine, Van Yuzuncu Yil University, Van, Turkey.
  • Department of Medical Biology, Faculty of Medicine, Van Yuzuncu Yil University, Van, Turkey.

ORCID-Profile: Eda Acikgoz, Cafer Tas, Mustafa Cakir, Seda Keskin

Förderung

  • Van Yuzuncu Yil University Scientific Research Projects Coordination Unit
  • Scientific and Technological Research Council of Turkey
  • Türkiye Bilimsel ve Teknolojik Araştirma Kurumu

Zitieren

APA

Acikgoz, E., Tas, C., Cakir, M., & Keskin, S. (2026). Loganin Modulates Inflammatory Signalling and Epidermal Alterations in an Imiquimod‐Induced Psoriasis Mouse Model. Journal of Biochemical and Molecular Toxicology, 40(11). https://doi.org/10.1002/jbt.71178

Vancouver

Acikgoz E, Tas C, Cakir M, Keskin S. Loganin Modulates Inflammatory Signalling and Epidermal Alterations in an Imiquimod‐Induced Psoriasis Mouse Model. Journal of Biochemical and Molecular Toxicology. 2026;40(11). doi:10.1002/jbt.71178

BibTeX
@article{Acikgoz2026,
  author = {Acikgoz, Eda and Tas, Cafer and Cakir, Mustafa and Keskin, Seda},
  title = {Loganin Modulates Inflammatory Signalling and Epidermal Alterations in an Imiquimod‐Induced Psoriasis Mouse Model},
  journal = {Journal of Biochemical and Molecular Toxicology},
  year = {2026},
  volume = {40},
  number = {11},
  doi = {10.1002/jbt.71178}
}
Kostenlos starten →